Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov
Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby

LOBBYING REGISTRATION

Lobbying Disclosure Act of 1995 (Section 4)

Check One: New Registrant New Client for Existing Registrant Amendment

1. Effective Date of Registration
3/8/2023
2. House Identification
 446430001
Senate Identification
 401105511-12

REGISTRANT Organization/Lobbying Firm Self Employed Individual

3. Registrant Organization
Life Sciences Pennsylvania
Address
411 Swedeland Road
Address2
​Suite 23-1080
City
King of Prussia
State
PA
Zip
19406
Country
USA

4. Principal place of business (if different than line 3)

City
State
Zip
Country
5. Contact name and telephone number International Number
Contact
​Mr. Kurt Imhof
Telephone
​6109476800
E-mail
​kimhof@lifesciencespa.org
6. General description of registrant’s business or activities
​Life sciences trade association

CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self

7. Client name
​Life Sciences Pennsylvania
Address
City
State
Zip
Country
​USA
8. Principal place of business (if different than line 7)
City
State
Zip
Country
9. General description of client’s business or activities

LOBBYISTS

10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.

Name Covered Official Position (if applicable)
First
Last
Suffix
​Lara ​Flynn

LOBBYING ISSUES

11. General lobbying issue areas (Select all applicable codes).

​BUD
​HCR
​TAX
​SMB
​SCI
​MMM
​INS
​ECN

12. Specific lobbying issues (current and anticipated)

Inform and educate congressional offices on the importance of Pennsylvania's life sciences community to patients and the Commonwealth's economy. Strong IP/Patent protections - e.g. Stronger Patents Act Protecting Medicare Part D and Part B Increases in NIH funding and Reauthorization of SBIR/STTR Programs Support legislation that improves public health - e.g. PAHPA Reauthorization and PASTEUR Act Access to medical technologies - e.g. Ensuring Patient Access to Critical Breakthrough Products Act, HR1691 Protecting the safety of the drug supply chain Encourage collaborative relationships between the industry and the FDA, e.g. User Fee Agreements Repealing R&D Tax Amortization - S866


AFFILIATED ORGANIZATIONS

13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?

No --> Go to line 14. Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14.

Internet Address:
Name Address Principal Place of Business
Street
City State/Province Zip Code Country
City
State
Country
City
State
Country
City
State
Country

FOREIGN ENTITIES

14. Is there any foreign entity

a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or

b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or

c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?

No --> Sign and date the registration. Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration.

Address Ownership
Name Street Principal place of business Amount of contribution
City State/Province Country
(city and state or country) for lobbying activities

City
State
Country
%
City
State
Country
%

CONVICTIONS DISCLOSURE

15. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?


Signature
Digitally Signed By: Kurt E Imhof
Date
4/6/2023 2:53:18 PM